ADIPOQ and breast carcinoma: Thus the inhibitory effect of adiponectin was clearly demonstrated on the estrogen-insensitive breast epithelial cancer cell line MDA-MB-231 and on the estrogen-sensitive breast cancer cell line MCF-7 [76], with the difference that ER-positive cells were inhibited at lower adiponectin concentrations than ER-negative cells [77].